Hematologic side effects
. | NCI grade . | . | . | ||
|---|---|---|---|---|---|
. | 0-1 n (%) . | 2-3 n (%) . | 4 n (%) . | ||
| Anemia | 21 (95) | 1 (5) | 0 (0) | ||
| Neutropenia | 17 (77) | 1 (5) | 4 (18)* | ||
| Thrombocytopenia | 18 (82) | 3 (13) | 1 (5) | ||
. | NCI grade . | . | . | ||
|---|---|---|---|---|---|
. | 0-1 n (%) . | 2-3 n (%) . | 4 n (%) . | ||
| Anemia | 21 (95) | 1 (5) | 0 (0) | ||
| Neutropenia | 17 (77) | 1 (5) | 4 (18)* | ||
| Thrombocytopenia | 18 (82) | 3 (13) | 1 (5) | ||
Total number of patients was 22.
After 8 to 12 weeks of treatment.